Delivery Order 75D30123D17920-75D30123F00002

Award Date 9/28/23
Potential Completion Date 9/27/26
Potential Value $912K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Boston, MA 02118, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded Boston Medical Center Corporation (BMC), a major safety-net hospital and academic medical center in Boston, Massachusetts, a $1,091,528 Delivery Order contract to provide Clinical Immunization Safety Assessment (CISA) services from September 2023 through September 2028. This contract is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle with an $86 million ceiling, which allows the CDC to order CISA...
This is a federal contract award to Boston Medical Center Corporation (BMC), a major safety-net hospital and academic medical center in Boston, Massachusetts. The contract was awarded by the Centers for Disease Control and Prevention (CDC) to provide Clinical Immunization Safety Assessment (CISA) services. The contract is a $742,721 delivery order under the CISA master IDIQ contract, which has a ceiling value of $86 million and runs from 2023 to 2028. The contract is not set aside. BMC is a...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $704,903.00 delivery order contract to Boston Medical Center Corporation, doing business as BMC, for clinical immunization safety assessment services. This delivery order is part of the larger Clinical Immunization Safety Assessment (CISA) indefinite delivery, indefinite quantity contract vehicle, which has a potential value of $86 million over 5-7 years. BMC, a private, not-for-profit academic...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Boston Medical Center Corporation (BMC), a private, not-for-profit academic medical center. The contract is a Delivery Order under the Clinical Immunization Safety Assessment (CISA) Master IDIQ, with a potential value of $728,754.00. BMC has provided clinical immunization safety assessment services to support the Department of Health and Human Services' immunization...
The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $900,221 delivery order contract to Childrens Hospital Medical Center, a non-profit healthcare organization in Cincinnati, Ohio. The contract is for the 2023 Clinical Immunization Safety Assessment (CISA) Base Indefinite Delivery, Indefinite Quantity (IDIQ) contract, which supports the CDC's vaccine safety monitoring program. The contract has a period of performance through September 27, 2026. Childrens Hospital Medical...
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) under the Clinical Immunization Safety Assessment (CISA) contract vehicle, a multiple-award indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract, valued at $697,827, was awarded to Childrens Hospital Medical Center (CHMC) in Cincinnati, Ohio, a non-profit hospital and research center. CHMC will provide CISA base services, including evaluating vaccine safety data and offering...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $792,763.00 delivery order contract to Childrens Hospital Medical Center, a non-profit hospital located in Cincinnati, Ohio. The contract is part of the Clinical Immunization Safety Assessment (CISA) indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle, which provides clinical and technical expertise to the CDC regarding vaccine safety issues. The delivery order was issued on September 15,...
The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $608,717 delivery order contract to Duke University's Office of Research Administration Division to provide Clinical Immunization Safety Assessment (CISA) services. The contract has a period of performance ending on September 30, 2020 and is not associated with a set-aside. This delivery order is part of a larger CISA indefinite delivery, indefinite quantity (IDIQ) contract with a...
This federal contract award is for a $518,366 delivery order under the Centers for Disease Control and Prevention's (CDC) Clinical Immunization Safety Assessment (CISA) IDIQ contract. The prime contractor is Childrens Hospital Medical Center (doing business as Children's Home Healthcare), a non-profit pediatric hospital and research center located in Cincinnati, Ohio. The contract is for pediatric COVID-19 vaccination services, with a period of performance through December 2025. No set-aside...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to the Cincinnati Children's Hospital Medical Center (Childrens Hospital Medical Center) to support the Clinical Immunization Safety Assessment (CISA) program. The $524,722.74 fixed-price delivery order contract was awarded on September 30, 2015 with a performance period ending on September 29, 2020. The contract was not set aside. Childrens Hospital Medical Center, a non-profit pediatric hospital and...
  • 75D30123D17920
    Indefinite Delivery Contract
  • 75D30123D17920-75D30123F00002
    Delivery Order

The Centers for Disease Control and Prevention (CDC) awarded a $912,168 delivery order contract to Boston Medical Center Corporation (BMC) to provide Clinical Immunization Safety Assessment (CISA) services from September 2023 through September 2026. This work supports the Department of Health and Human Services' immunization safety programs. BMC is a major safety-net hospital and academic medical center in Boston that conducts extensive biomedical and clinical research, participates in public health initiatives, and provides healthcare services. The contract is an Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle, which allows for future delivery orders related to immunization safety assessments. There is no set-aside designation for this award.

Generated 8/22/24, 3:29 PM